|
Trial no.:
|
PACTR202609467782861 |
Date of Registration:
|
07/09/2026 |
|
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
| TRIAL DESCRIPTION |
|
Public title
|
Effect of double versus triple analgesia on post-caesarean pain relief at Rivers State University Teaching Hospital |
| Official scientific title |
Effect of double versus triple analgesia on post-caesarean pain relief at Rivers State University Teaching Hospital |
|
Brief summary describing the background
and objectives of the trial
|
Background
Caesarean section remains one of the most frequently performed surgical procedures worldwide and constitutes a major component of modern obstetric practice. Although advances in surgical techniques, anaesthesia and perioperative care have significantly improved maternal outcomes and postoperative pain following caesarean delivery remains a major challenge. Effective post-caesarean analgesia facilitates early ambulation, promotes maternal-infant bonding, enhances breastfeeding success, reduces postoperative complications and improves maternal satisfaction. Conversely, inadequate pain control may delay recovery, impair neonatal care, prolong hospital stay, increase complication risks and healthcare costs.
Multimodal analgesia, involving the combination of analgesics with different mechanisms of action, has become the recommended approach for postoperative pain management. At the Rivers State University Teaching Hospital, a combination of rectal diclofenac and intramuscular pentazocine is commonly employed for post-caesarean pain relief. However, some clinicians additionally administer intramuscular paracetamol as part of a triple-agent analgesic regimen. Despite the widespread use of both regimens, there is limited evidence within the local environment regarding their comparative effectiveness.
SPECIFIC OBJECTIVES
1. To compare the mean postoperative pain scores among women receiving double-agent analgesia (rectal diclofenac and intramuscular pentazocine) and those receiving triple-agent analgesia (rectal diclofenac, intramuscular pentazocine and intramuscular paracetamol) following caesarean section.
2. To compare the proportion of women requiring rescue (additional) analgesia in double-agent versus triple-agent groups.
3. To compare maternal satisfaction with postoperative pain management between the two groups.
4. To compare postoperative recovery outcomes, including time to ambulation and duration of hospital stay, between the two groups.
|
| Type of trial |
RCT |
| Acronym (If the trial has an acronym then please provide) |
DVTA |
| Disease(s) or condition(s) being studied |
Obstetrics and Gynecology |
| Sub-Disease(s) or condition(s) being studied |
|
| Purpose of the trial |
Education /Training |
| Anticipated trial start date |
01/10/2026 |
| Actual trial start date |
01/10/2026 |
| Anticipated date of last follow up |
31/03/2027 |
| Actual Last follow-up date |
31/03/2027 |
| Anticipated target sample size (number of participants) |
100 |
| Actual target sample size (number of participants) |
100 |
| Recruitment status |
Not yet recruiting |
| Publication URL |
|
|